Reporting owner · Q3 2026 · CIK 1851564

Ashish Arora: insider trades.

Ashish Arora reported 17 non-derivative transactions on 8 SEC ownership filings in Q3 2026: 0 open-market purchases and 15 sales ($4.0M), across 1 company.

Transactions
17
Purchases (P)
0
Sales (S)
15
Companies
1
Name as filed
Ashish Arora

Companies

CompanyRelationshipTransactions
Cricut, Inc. (CRCT)Director, Officer, TenPercentOwner · Chief Executive Officer17

Transactions

17 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-17Cricut, Inc.S60,000$5.685,417,105Form 4
2026-09-16Cricut, Inc.S60,000$5.555,477,105Form 4
2026-09-15Cricut, Inc.S60,000$5.625,537,105Form 4
2026-09-04Cricut, Inc.S60,000$5.615,597,105Form 4
2026-09-03Cricut, Inc.S60,000$5.855,657,105Form 4
2026-09-02Cricut, Inc.S60,000$5.795,717,105Form 4
2026-08-19Cricut, Inc.C1,750,000—5,777,105Form 4
2026-08-19Cricut, Inc.S60,000$5.484,027,105Form 4
2026-08-18Cricut, Inc.S60,000$5.534,087,105Form 4
2026-08-17Cricut, Inc.S60,000$5.64,147,105Form 4
2026-08-05Cricut, Inc.S1,905$6.264,207,105Form 4
2026-08-05Cricut, Inc.S58,095$5.984,209,010Form 4
2026-08-04Cricut, Inc.S60,000$4.894,267,105Form 4
2026-08-03Cricut, Inc.S60,000$4.774,327,105Form 4
2026-07-21Cricut, Inc.A65,212$04,387,105Form 4
2026-07-17Cricut, Inc.S2,282$4.754,321,893Form 4
2026-07-15Cricut, Inc.S1,051$4.754,324,175Form 4

Questions

What stock did Ashish Arora buy or sell?

Ashish Arora reported 17 non-derivative transactions on 8 SEC ownership filings in Q3 2026: 0 open-market purchases and 15 sales ($4.0M), across 1 company.

Is Ashish Arora the same person as other filers with this name?

This page covers SEC CIK 1851564 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/ashish-arora-1851564.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.